1-7 of 7
Vladimir Vdovin, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prophylactic Treatment with New Recombinant Factor IX Innonafactor (Russia) in Adolescent and Adult Patients with Hemophilia B

Ekaterina Shiller, Victor Petrov, MD PhD, Pavel Svirin, MD, Vladimir Vdovin, MD, Igor Koltunov, MD PhD, Artyom Bullih, Michael A Maschan, Dmitry Kudlay, MD PhD Prof., Ekaterina Klykova, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4895.
https://doi.org/10.1182/blood.V130.Suppl_1.4895.4895
Published: 2017
Journal Articles

Long-Term Prophylaxis with Activated Recombinant FVII in Children with Hemophilia a and Inhibitor, Receiving Treatment with ITI Protocol

Ekaterina Shiller, MD, Victor Petrov, MD PhD, Pavel Svirin, MD, Vladimir Vdovin, MD, Igor Koltunov, MD PhD, Artem Bullikh, MD, Eugene Nikitin, MD PhD, Dmitry Kudlay, MD PhD Prof., Ekaterina Klykova, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4980.
https://doi.org/10.1182/blood.V128.22.4980.4980
Published: 2016
Journal Articles

Safety and Efficacy of New Moroctocog Alfa Drug (Octofactor) in Prophylactic Treatment in Adolescent Patients with Severe and Moderate Hemophilia a

Ekaterina Shiller, MD, Vladimir Vdovin, MD, Victor Petrov, MD PhD, Pavel Svirin, MD, Tatiana Andreeva, MD PhD, Inna Lavrichenko, MD, Artem Bullikh, MD, Igor Koltunov, MD PhD, Igor Davydkin, Prof., Igor Kurtov, MD PhD, Alexandr Shuster, Academician, PhD, Dmitry Kudlay, MD PhD Prof., Sergey Lukyanov, MD PhD, Anton Borozinets, MD PhD, Eugene Nikitin, MD PhD, Ekaterina Klykova, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4703.
https://doi.org/10.1182/blood.V126.23.4703.4703
Published: 2015
Journal Articles

Efficacy, Immunogenicity, Pharmacokinetics, and Safety Of Human-cl rhFVIII – a GCP Study In Children With Severe Haemophilia A

Raina Liesner, Martina Jansen, Anna Klukowska, Vladimir Vdovin, MD, Tomasz Szczepanski, MD, PHD, Sigurd Knaub, PhD
Journal: Blood
Blood (2013) 122 (21): 3594.
https://doi.org/10.1182/blood.V122.21.3594.3594
Published: 2013
Journal Articles

Latest Results From The PUP-GCP Clinical Trial: A Low Inhibitor Rate In Previously Untreated Patients With Severe Hemophilia A Treated With Octanate

Anna Klukowska, Martina Jansen, Vladimir Komrska, MD, Pawel Laguna, MD, PhD, Vladimir Vdovin, MD, Sigurd Knaub, PhD
Journal: Blood
Blood (2013) 122 (21): 3596.
https://doi.org/10.1182/blood.V122.21.3596.3596
Published: 2013
Journal Articles

ITI with a VWF-Stabilised FVIII Concentrate in Haemophilia A Patients with Inhibitors and a Poor Prognosis for ITI Success: Progress Report on octanate ® in the Observational ObsITI Study,

Carmen Escuriola-Ettingshausen, MD, Vladimir Vdovin, MD, Nadezhda Zozulya, MD, PhD, Olga Plyushch, Prof, Wolfhart Kreuz, MD, Bruce A. Schwartz, PhD
Journal: Blood
Blood (2011) 118 (21): 3310.
https://doi.org/10.1182/blood.V118.21.3310.3310
Published: 2011
Journal Articles

Immune Tolerance Therapy in Children with FVIII Inhibitors

Vladimir Vdovin, MD, Pavel Svirin, MD, Ekaterina Shiller, MD, Bruce A. Schwartz, PhD
Journal: Blood
Blood (2011) 118 (21): 4656.
https://doi.org/10.1182/blood.V118.21.4656.4656
Published: 2011